Results

Total Results: 2,208 records

Showing results for "drug".

321. Enzyme-Replacement Therapies for Lysosomal Storage Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
     December 01, 2019 - Food and Drug Administration (FDA)-approved ERT for the treatment of six LSDs. … Technical Brief is to report what outcomes (benefits and harms) have been studied for a technology, drug … effectiveness review or systematic review that draws conclusions as to the clinical benefits and harms of a drug

322. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/psoriasis-chronic/research
     December 01, 2019 - effectiveness of biologic systemic agents versus nonbiologic systemic agents or phototherapy, on an individual drug … RCTs) and observational studies were included in our review if they compared treatment with Food and Drug … systemic biologic agents with either systemic nonbiolgic agents or with phototherapy on an individual drug

323. Immune System and Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/immune-system-and-disorders?page=2
     May 02, 2011 - Asthma Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Arthritis Systematic Review Archived November 19, 2007 Comparative Effectiveness of Drug

324. #05 DEPRESSION (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Personalized drug therapy has traditionally lagged behind behavioral therapy in this regard because … Biopharm Drug Dispos. 2003 Jan;24(1):37-43. Also available: http://dx.doi.org/10.1002/bdd.336. … Drug Enforcement Administration. … Research suggests new drug targets for depression. … Washington (DC): Drug Enforcement Administration, U.S.

325. Topic-Brief3-Sud (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
     April 01, 2021 - Pain perception in drug-free and in methadone-maintained human ex- addicts. … Drug overdose deaths in the United States, 1999– 2018. NCHS Data Brief No. 356. … Drug Alcohol Depend. 2018 Dec 1;193:142-7. doi: 10.1016/j.drugalcdep.2018.10.002. … Drug Alcohol Depend. 2004 Jan 7;73(1):23-31. doi: 10.1016/j.drugalcdep.2003.08.007. … Drug and alcohol dependence. 2019;203:61-5. PMID: CN-01978075. 50.

326. CER 229 Evidence Summary: Opioid Treatments for Chronic Pain (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
     April 01, 2020 - Annual Surveillance Report of Drug-Related Risks and Outcomes--United States, 2017. … Drug Abuse Warning Network. … The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) findings on drug-related … Drug Alcohol Depend. 2015 Jun 01;151:47-55. doi: 10.1016/j. drugalcdep.2015.02.033. … Food & Drug Administration, Drug Safety Communications; 2019.

327. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/D
     Digestive Diseases Disabilities Diverticulosis and Diverticulitis Domestic Violence Down Syndrome Drug … Abuse Drug Reactions Drugs and Young People Dual Diagnosis Back to Top

328. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/d
     Digestive Diseases Disabilities Diverticulosis and Diverticulitis Domestic Violence Down Syndrome Drug … Abuse Drug Reactions Drugs and Young People Dual Diagnosis Back to Top

329. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
     March 23, 2019 - within class o Same drug(s), different route, treatment duration, initiation time, or other aspect … Food and Drug Administration, other international equivalent agencies, and pharmacopoeia. … For drug levels not available from the databases, we will search for existing systematic reviews. … Curr Drug Metab. 2012 May 1;13(4):474-90. PMID: 22299823. 15. U.S. … Food and Drug Administration.

330. Comparative Effectiveness of First and Second Generation Antipsychotics in the Adult Population | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics-adults/research-protocol
     December 01, 2019 - Study inclusion in the CER will not be limited by drug dosage. … Food and Drug Administration (FDA). Comparators: Any commercially available FDA-approved SGA. … Drug dosage. Followup period. Previous exposure to antipsychotics. … All methods of drug delivery (e.g., tablet, liquid, injection) will be eligible. … (neuroleptic adj2 (agent* or drug*)).tw. 28. or/25-27 29.

331. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
     January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Phase III clinical trials for florbetapir have been completed and a new drug application was submitted … Food and Drug Administration (FDA) in January 2011 that FDA considered and led to ongoing controversy … Committee briefing document: Peripheral and central nervous system drugs advisory committee: New drug … Food and Drug Administration (FDA); 2010 Dec 20. 86 p.

332. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - This drug was approved for marketing in January 2012 and is now classified as diffused according to … Patients treated with the drug were reported to have a longer median time to the first exacerbation … about $44, so the drug would be relatively inexpensive for long-term, prophylactic use … could reduce the cost of the drug for patients who struggle with the cost of drug co- payments. … Food and Drug Administration (FDA) [accessed 2012 Jun 28]. [2 p].

333. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - , the drug may be cost saving. … MS drug under investigation after 11 deaths. In: Drug Discovery & Development [internet]. … Anthem Blue Cross California drug list. … Specialty pharmacy program drug list. … Food and Drug Administration (FDA).

334. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Food and Drug Administration (FDA); 2014 Nov 19. 2 p. … Food and Drug Administration (FDA); 2014 Nov 19. 3 p. … Food and Drug Administration; 1993 Nov 19 [accessed 2015 Sep 11]. [2 p]. … Food and Drug Administration (FDA); 1 p. … Food and Drug Administration; 1992 Nov 24 [accessed 2015 Sep 11]. [2 p].

335. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/indirect-comparisons/research
     September 01, 2019 - Food and Drug Administration reviews, trial registries, and research grant databases up to November 2011

336. Finding Evidence for Comparing Medical Interventions (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
     January 01, 2011 - Reference bias in reports of drug trials. … Exp LIVER DISEASES/ci Drug terms AND Exp LIVER DISEASE/si subheadings linked to drug name Exp … DRUG NAMEadverse events, po, to Exp DRUG NAMEadverse events, to floating subheadings Drug terms … Drug terms AND (ae OR to OR co).fs. … terms AND exp DRUG TOXICITY/ Drug terms AND (exp ADVERSE DRUG REACTION/ OR Exp Side- Effect/ )

337. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
     December 06, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) for the treatment RA at the time of the first review. … The Key Questions (KQs) Question 1: For patients with RA, do drug therapies differ in their ability … Question 3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence … Food and Drug Administration (FDA).

338. Crosscutting-Horizon-Scan-High-Impact-1512 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Food and Drug Administration (FDA). … Food and Drug Administration (FDA). 510(k) summary for Raisin personal monitor [K093976]. … Food and Drug Administration (FDA); 2010 Mar 25 [accessed 2010 Dec 27]. [10 p]. … Food and Drug Administration (FDA); 2012 May 14. 10 p. … FDA accepts first digital medicine New Drug Application for Otsuka and Proteus Digital Health.

339. Comparative Effectiveness of Medications in Patients with Epilepsy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
     March 01, 2012 - All that can be said is that a particular drug or class of drug is effective in some patients and not … If the drug was working in the first place, why would the patient be put back on the old drug rather … class of drug on the epilepsy syndrome. … Therefore, when exploring this topic, concentration, drug-drug interactions, and the fact that phenytoin … the first drug prescribed for the patient.

340. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - Nevertheless, the drug is still widely prescribed. … , and single drug versus single drug comparisons for drugs within the same class and across classes … versus placebo, and comparisons of drug versus drug, for drugs within the same class and across classes … The Food and Drug Administration’s Osteoporosis Guidance Document: past, present, and future. … Rockville, MD: Food and Drug Administration, Division of Metabolic and Endocrine Drug Products; 1994